Potential application mechanism of traditional Chinese medicine in treating immune checkpoint inhibitor-induced colitis
- PMID: 38660314
- PMCID: PMC11039877
- DOI: 10.3389/fimmu.2024.1366489
Potential application mechanism of traditional Chinese medicine in treating immune checkpoint inhibitor-induced colitis
Abstract
Cancer ranks among the foremost causes of mortality worldwide, posing a significant threat to human lives. The advent of tumor immunotherapy has substantially transformed the therapeutic landscape for numerous advanced malignancies, notably non-small cell lung cancer and melanoma. However, as immune checkpoint inhibitors (ICIs) are increasingly applied in clinical settings, a spectrum of undesired reactions, termed immune-related adverse events (irAEs), has emerged. These adverse reactions are associated with immunotherapy and can result in varying degrees of harm to the human body. Among these reactions, Immune checkpoint inhibitor-induced colitis (ICIIC) stands out as one of the most prevalent clinical adverse events. In contemporary times, traditional Chinese medicine (TCM) has demonstrated remarkable efficacy in addressing various maladies. Consequently, investigating the potential application and mechanisms of Chinese medicine in countering immune checkpoint inhibitor-induced colitis assumes significant importance in the treatment of this condition.
Keywords: immune; immune checkpoint inhibitor-induced colitis; mechanisms; potential application; traditional Chinese medicine.
Copyright © 2024 Wang, Guo, Shen, Xie and Xiang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
An updated review on immune checkpoint inhibitor-induced colitis: epidemiology, pathogenesis, treatment strategies, and the role of traditional Chinese medicine.Front Immunol. 2025 Mar 17;16:1551445. doi: 10.3389/fimmu.2025.1551445. eCollection 2025. Front Immunol. 2025. PMID: 40165945 Free PMC article. Review.
-
Traditional Chinese medicine enhances the effectiveness of immune checkpoint inhibitors in tumor treatment: A mechanism discussion.J Ethnopharmacol. 2025 Feb 10;338(Pt 1):118955. doi: 10.1016/j.jep.2024.118955. Epub 2024 Oct 18. J Ethnopharmacol. 2025. PMID: 39427737 Review.
-
Traditional Chinese medicine and its components effectively reduce resistance mediated by immune checkpoint inhibitors.Front Immunol. 2024 Nov 26;15:1429483. doi: 10.3389/fimmu.2024.1429483. eCollection 2024. Front Immunol. 2024. PMID: 39660124 Free PMC article. Review.
-
Immune checkpoint inhibitor-related colitis in patients on immunotherapy for cancer.Am J Clin Pathol. 2024 Jul 5;162(1):17-27. doi: 10.1093/ajcp/aqae002. Am J Clin Pathol. 2024. PMID: 38377034 Review.
-
Immune checkpoint inhibitor colitis, a rising issue in targeted cancer therapy era: A literature review.Rom J Intern Med. 2024 Apr 9;62(3):219-230. doi: 10.2478/rjim-2024-0015. Print 2024 Sep 1. Rom J Intern Med. 2024. PMID: 38595047 Review.
Cited by
-
Bibliometric analysis of traditional Chinese medicine in cancer treatment via immune system modulation (2015-2025).Front Immunol. 2025 May 8;16:1581885. doi: 10.3389/fimmu.2025.1581885. eCollection 2025. Front Immunol. 2025. PMID: 40406101 Free PMC article.
-
An updated review on immune checkpoint inhibitor-induced colitis: epidemiology, pathogenesis, treatment strategies, and the role of traditional Chinese medicine.Front Immunol. 2025 Mar 17;16:1551445. doi: 10.3389/fimmu.2025.1551445. eCollection 2025. Front Immunol. 2025. PMID: 40165945 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources